MSB 9.20% $1.19 mesoblast limited

Till FDA stamp approval for remestemcel-L, celebration is too...

  1. 424 Posts.
    lightbulb Created with Sketch. 30
    Till FDA stamp approval for remestemcel-L, celebration is too early.
    From my points view, high possibility,90%?

    Then another milestone is earlier Sep/2020, COVID-19 readout for 90 patients.

    For long holder, just waiting solid news coming.
  2. This thread is closed.

    You may not reply to this discussion at this time.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.19
Change
-0.120(9.20%)
Mkt cap ! $1.364B
Open High Low Value Volume
$1.27 $1.30 $1.17 $8.256M 6.654M

Buyers (Bids)

No. Vol. Price($)
11 34133 $1.18
 

Sellers (Offers)

Price($) Vol. No.
$1.19 14884 8
View Market Depth
Last trade - 10.52am 24/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.